The 19-kD antigen and protective immunity in a murine model of tuberculosis

Clinical and Experimental Immunology

Volumn 120, Issue 2, 2000, Pages 274-279

  Yeremeev, V V ^a   Lyadova, I V ^a   Nikonenko, B V ^a   Apt, Alexander S ^a   Abou Zeid, C ^b   Inwald, J ^b   Young, D B ^b  

^a CENTRAL TUBERCULOSIS RESEARCH INSTITUTE   (Russian Federation)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Immune response; Mouse model; Recombinant vaccines; Tuberculosis

Indexed keywords

ANTIBODY; BCG VACCINE; DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 5; MYCOBACTERIUM ANTIGEN; RECOMBINANT VACCINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE INACTIVATION; IMMUNE SYSTEM; IMMUNITY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; TUBERCULOSIS; VACCINATION;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BCG VACCINE; DISEASE MODELS, ANIMAL; MICE; MICE, INBRED C57BL; MYCOBACTERIUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; RECOMBINANT FUSION PROTEINS; TIME FACTORS; TUBERCULOSIS; VACCINATION; VACCINES, DNA;

EID: 0034111387     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01212.x     Document Type: Article

References (24)

1. 1 Engers HD, Houba V, Bennedsen J et al. Results of a World Health Organization-sponsored workshop to characterize antigens recognized by mycobacterium-specific monoclonal antibodies. Infect Immun 1986; 51:718-20.
2. 2 Jackett PS, Bothamely GH, Bathra HV et al. Specificity of antibodies to immunodominant mycobacterial antigens in pulmonary tuberculosis. J Clin Microbiol 1988; 26:2313-8.
3. 3 Faith A, Moreno C, Lathigra R et al. Analysis of human T-cell epitopes in the 19, 000 MW antigen of Mycobacterium tuberculosis: influence of HLA-DR. Immunology 1991; 74:1-7.
4. 4 Harris DP, Vordermeier HM, Friscia G et al. Genetically permissive recognition of adjacent epitopes from the 19-kDa antigen of Mycobacterium tuberculosis by human and murine T-cells. J Immunol 1993; 150:5041-50.
5. 5 Young DB, Kaufmann SHE, Hermans PWM, Thole JER. Mycobacterial protein antigens: a compilation. Mol Microbiol 1992; 6:133-45.
6. 6 Garbe TR, Harris D, Vordermeier HM et al. Expression of the Mycobacterium tuberculosis 19-kilodalton antigen in Mycobacterium smegmatis: immunological analysis and evidence of glycosylation. Infect Immun 1993; 61:260-7.
7. 7 Abou-Zeid C, Gares M-P, Inwald J et al. Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae. Infect Immun 1997; 65:1856-62.
8. 8 Zhang Y, Lathigra R, Garbe T, Catty D, Young DB. Genetic analysis of superoxide dismutase, the 23 kDa antigen of Mycobacterium tuberculosis. Mol Microbiol 1991; 5:381-91.
9. 9 Garbe TR, Barathi J, Barnini S et al. Transformation of mycobacterial species using hygromycin resistance as selectable marker. Microbiology 1994; 140:133-8.
10. 10 Huygen K, Content J, Denis O et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nature Med 1996; 2:893-8.
11. 11 Holt PG, Degebrodt AO, Leary C, Krska K, Plozza T. T cell activation by antigen-presenting cells from lung tissue digests: suppression by endogenous macrophages. Clin Exp Immunol 1985; 62:586-93.
12. 12 Lyadova IV, Yeremeev VV, Majorov KB et al. An ex vivo study of T lymphocytes recovered from the lungs of I/St mice infected with and susceptible to Mycobacterium tuberculosis. Infect Immun 1998; 66:4981-8.
13. 13 Apt AS, Avdienko VG, Nikonenko BV, Moroz AM, Skamene E. Distinct H-2 complex control of mortality, and immune responses to tuberculosis infection in virgin and BCG-vaccinated mice. Clin Exp Immunol 1993; 94:322-9.
14. 14 Yeremeev VV, Majorov KB, Avdienko VG, Kondrashov SV, Apt AS. Experimental analysis of Mycobacterium smegmatis as a possible vector for the development of the new antituberculosis vaccines. Probl Tuberculeza 1996; N1:49-52(in Russian).
15. 15 Orme IM, Anderson P, Boom WH. T cell response to Mycobacterium tuberculosis. J Infect Dis 1993; 167:1481-97.
16. 16 Rook GAW, Hernandez-Pando R. The pathogenesis of tuberculosis. Annu Rev Microbiol 1996; 50:259-84.
17. 17 Nikonenko BV, Apt AS, Mezhlumova MB et al. Influence of the mouse Bcg. Tbc-1 and xid genes on resistance and immune responses to tuberculosis infection and efficacy of BCG vaccination. Clin Exp Immunol 1996; 104:37-43.
18. 18 Cole ST, Brosch R, Parkhill J et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998; 393:537-44.
19. 19 WHO Meeting on the GVP Task Force on Animal Models for Tuberculosis, 11 February, Statens Seruminstitut, Copenhagen, 1999.
20. + T-cell priming against the identified peptides after DNA-vaccination of mice. Vaccine 1998; 16:692-7.
21. + T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect Immun 1998; 66:1527-33.
22. 22 Zhu X, Venkataprasad N, Thangaraj HS et al. Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. J Immunol 1997; 158:5921-6.
23. 23 Tascon RE, Colston MJ, Ragno S et al. Vaccination against tuberculosis by DNA injection. Nature Med 1996; 2:888-92.
24. 24 Zhu X, Venkataprasad N, Ivanyi J, Vordermeier HM. Vaccination with recombinant vaccinia viruses protects mice against Mycobacterium tuberculosis infection. Immunology 1997; 92:6-9.